JP2023541522A5 - - Google Patents
Info
- Publication number
- JP2023541522A5 JP2023541522A5 JP2023507550A JP2023507550A JP2023541522A5 JP 2023541522 A5 JP2023541522 A5 JP 2023541522A5 JP 2023507550 A JP2023507550 A JP 2023507550A JP 2023507550 A JP2023507550 A JP 2023507550A JP 2023541522 A5 JP2023541522 A5 JP 2023541522A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- membered
- compound
- unsubstituted
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PLPCT/PL2020/000066 | 2020-08-03 | ||
| PL2020000066 | 2020-08-03 | ||
| PCT/EP2021/071694 WO2022029138A1 (en) | 2020-08-03 | 2021-08-03 | Low molecular weight protein degraders and their applications |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023541522A JP2023541522A (ja) | 2023-10-03 |
| JP2023541522A5 true JP2023541522A5 (cg-RX-API-DMAC7.html) | 2024-07-25 |
Family
ID=72193535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507550A Pending JP2023541522A (ja) | 2020-08-03 | 2021-08-03 | 低分子量タンパク質分解物質及びその適用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240294489A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4188373A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023541522A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230048373A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116457344B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021319847A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023001956A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3186919A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL300308A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023001401A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022029138A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117440948A (zh) * | 2021-06-28 | 2024-01-23 | 成都分迪药业有限公司 | 酰胺类化合物及其用途 |
| CN114933584B (zh) * | 2021-08-09 | 2022-12-27 | 上海贵之言医药科技有限公司 | 一种二氢-2h-异吲哚酯类化合物 |
| CN116082301A (zh) * | 2021-11-05 | 2023-05-09 | 上海美志医药科技有限公司 | 具有降解gspt1活性的化合物及其应用 |
| WO2023085785A1 (ko) * | 2021-11-09 | 2023-05-19 | 한국화학연구원 | 글루타이미드 모핵을 갖는 이소인돌리논 유도체 및 이의 용도 |
| AU2022405474B2 (en) * | 2021-12-08 | 2026-08-13 | Gluetacs Therapeutics (Shanghai) Co., Ltd. | E3 ubiquitin ligase ligand compound, protein degrader developed based thereon and their applications |
| CN118488948A (zh) | 2021-12-22 | 2024-08-13 | 吉利德科学公司 | Ikaros锌指家族降解剂及其用途 |
| US20240124412A1 (en) * | 2021-12-22 | 2024-04-18 | Gilead Sciences, Inc. | Ikaros zinc finger family degraders and uses thereof |
| PL4245756T3 (pl) | 2022-03-17 | 2025-02-17 | Gilead Sciences, Inc. | Środki degradujące palec cynkowy z rodziny ikaros i ich zastosowania |
| CN114835680A (zh) * | 2022-04-29 | 2022-08-02 | 成都分迪药业有限公司 | 卤素取代异吲哚啉化合物及其应用 |
| CN115636811A (zh) * | 2022-08-17 | 2023-01-24 | 成都分迪药业有限公司 | 异吲哚啉苄胺衍生物的合成方法 |
| JP2025531869A (ja) | 2022-09-09 | 2025-09-25 | イノヴォ セラピューティクス、インコーポレイテッド | CK1αおよびDUAL CK1α/GSPT1分解化合物 |
| WO2024096753A1 (en) | 2022-11-02 | 2024-05-10 | Captor Therapeutics S.A. | Nek7 degraders and methods of use thereof |
| WO2025179161A1 (en) | 2024-02-21 | 2025-08-28 | Innovo Therapeutics, Inc. | Protein degrading compounds |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5635517B1 (en) | 1996-07-24 | 1999-06-29 | Celgene Corp | Method of reducing TNFalpha levels with amino substituted 2-(2,6-dioxopiperidin-3-YL)-1-oxo-and 1,3-dioxoisoindolines |
| US6306663B1 (en) | 1999-02-12 | 2001-10-23 | Proteinex, Inc. | Controlling protein levels in eucaryotic organisms |
| US7323479B2 (en) | 2002-05-17 | 2008-01-29 | Celgene Corporation | Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline |
| US8877780B2 (en) * | 2006-08-30 | 2014-11-04 | Celgene Corporation | 5-substituted isoindoline compounds |
| AU2007290407A1 (en) * | 2006-08-30 | 2008-03-06 | Celgene Corporation | 5-substituted isoindoline compounds |
| HUE035389T2 (en) | 2006-09-26 | 2018-05-02 | Celgene Corp | 5-substituted quinazolinone derivatives as anticancer agents |
| SG183257A1 (en) | 2010-02-11 | 2012-09-27 | Celgene Corp | Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same |
| US8927725B2 (en) * | 2011-12-02 | 2015-01-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Thio compounds |
| US9499514B2 (en) * | 2014-07-11 | 2016-11-22 | Celgene Corporation | Antiproliferative compounds and methods of use thereof |
| CN121974842A (zh) | 2016-05-10 | 2026-05-05 | C4医药公司 | 用于靶蛋白降解的胺连接的c3-戊二酰亚胺降解决定子体 |
| CN109562107A (zh) * | 2016-05-10 | 2019-04-02 | C4医药公司 | 用于靶蛋白降解的杂环降解决定子体 |
| WO2017197056A1 (en) * | 2016-05-10 | 2017-11-16 | C4 Therapeutics, Inc. | Bromodomain targeting degronimers for target protein degradation |
| IL319363A (en) * | 2017-01-31 | 2025-05-01 | Arvinas Operations Inc | Cervalon ligands and bifunctional compounds containing them |
| WO2018169777A1 (en) * | 2017-03-14 | 2018-09-20 | Biotheryx, Inc. | Compounds targeting proteins, compositions, methods, and uses thereof |
| EP4717317A3 (en) | 2017-06-20 | 2026-06-03 | C4 Therapeutics, Inc. | N/o-linked degrons and degronimers for protein degradation |
| JP7258009B2 (ja) | 2017-07-10 | 2023-04-14 | セルジーン コーポレイション | 抗増殖化合物及びその使用方法 |
| TWI793151B (zh) * | 2017-08-23 | 2023-02-21 | 瑞士商諾華公司 | 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途 |
| CA3075813A1 (en) * | 2017-10-04 | 2019-04-11 | Dana-Farber Cancer Institute, Inc. | Small molecule inhibition of transcription factor sall4 and uses thereof |
| US10905684B2 (en) * | 2018-06-13 | 2021-02-02 | Biotheryx, Inc. | Aminoamide compounds |
| EA202191833A1 (ru) * | 2018-12-31 | 2021-10-11 | Селджин Корпорейшн | Композиции и способы применения 2-(4-хлорфенил)-n-((2-(2,6-диоксопиперидин-3-ил)-1-оксоизоиндолин-5-ил)метил)-2,2-дифторацетамида |
-
2021
- 2021-08-03 AU AU2021319847A patent/AU2021319847A1/en active Pending
- 2021-08-03 JP JP2023507550A patent/JP2023541522A/ja active Pending
- 2021-08-03 EP EP21758624.7A patent/EP4188373A1/en active Pending
- 2021-08-03 CN CN202180067832.3A patent/CN116457344B/zh active Active
- 2021-08-03 CA CA3186919A patent/CA3186919A1/en active Pending
- 2021-08-03 IL IL300308A patent/IL300308A/en unknown
- 2021-08-03 KR KR1020237007785A patent/KR20230048373A/ko active Pending
- 2021-08-03 WO PCT/EP2021/071694 patent/WO2022029138A1/en not_active Ceased
- 2021-08-03 MX MX2023001401A patent/MX2023001401A/es unknown
- 2021-08-03 US US18/040,383 patent/US20240294489A1/en active Pending
- 2021-08-03 BR BR112023001956A patent/BR112023001956A2/pt unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN116457344B (zh) | 低分子量蛋白质降解剂及其应用 | |
| CN109789146B (zh) | 趋化因子受体调节剂及其用途 | |
| JP2017533922A5 (cg-RX-API-DMAC7.html) | ||
| JP2006515587A (ja) | 性的不能を治療する方法 | |
| CN102083773A (zh) | {f-19}标记的l-谷氨酸和l-谷氨酰胺衍生物(ⅲ)、其用途和制备方法 | |
| CN110248662A (zh) | 一种治疗前列腺癌的组合、药物组合物及治疗方法 | |
| EP3784662B1 (fr) | Composes a activite inhibitrice de la polymerisation de la tubuline et aux proprietes immunomodulatrices | |
| JP2019509986A (ja) | トリプトライドのグルコース・コンジュゲート、その類縁体及び使用 | |
| JP2022521081A (ja) | Hbv感染若しくはhbv誘導性疾患の治療において有用なアミド誘導体 | |
| JP2007505044A5 (cg-RX-API-DMAC7.html) | ||
| JP2022169780A5 (cg-RX-API-DMAC7.html) | ||
| US10077236B2 (en) | Azacyclic constrained analogs of FTY720 | |
| WO2018068665A1 (zh) | 微管蛋白抑制剂 | |
| BR112012020377B1 (pt) | Uso de um composto ou sal farmaceuticamente aceitável do mesmo e embalagem comercial | |
| AU2021328979A1 (en) | Pyrazole boronic acid compound, pharmaceutical composition containing same, and uses thereof | |
| WO2013075199A1 (pt) | "compostos acil-hidrazonas e oxadiazóis, composições farmacêuticas compreendendo os mesmos e seus usos | |
| RU2004111787A (ru) | Ретиноидные агонисты (1), производные алкилмочевины | |
| BRPI0906248B1 (pt) | composto, composição farmacêutica para inibir a formação de microtúbulos e método para preparar um composto | |
| JP2023550035A (ja) | がん治療におけるmetap2阻害剤及びcdk4/6阻害剤の組み合わせ | |
| CN108473449B (zh) | 一种作为吲哚胺-2,3-双加氧酶抑制剂的砜脒及其制备方法和用途 | |
| AU2017355566A1 (en) | Inhibitors of mtor-deptor interactions and methods of use thereof | |
| US10093609B2 (en) | TAK1 kinase inhibitors, compositions, and uses related thereto | |
| WO2023224128A1 (ja) | 線維症の治療又は予防のための医薬組成物 | |
| RU2004111789A (ru) | Ретиноидные агонисты | |
| RU2800042C1 (ru) | Спиросоединения в качестве ингибиторов ERK и их применение |